Citations 1
A phase I trial of the safety and immunogenicity of a multi-epitope folate receptor alpha peptide vaccine used in combination with cyclophosphamide in subjects previously treated for breast or ovarian cancer.
Kalli, Kimberly R., Block, Matthew S. , Hobday, Timothy J. , Dockter, Travis , Erskine, Courtney L. , Visscher, Daniel W., Wilson, G. Haswell , Shreeder, Barath , Knutson, Keith L. , Kasi, Pashtoon Murtaza , Suman, Vera J. , Wilson, Glynn, Knutson, Keith L.
Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e14028-e14028
